Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil-Reference-Cited by-同舟云学术

Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil

Published:2016-07-11 Issue:2 Volume:3 Page:353-361
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Machado Marina Amaral de Ávila,Ferre Felipe,Moura Cristiano Soares de,Almeida Alessandra Maciel,Andrade Eli Iola Gurgel,Cherchiglia Mariângela Leal,Acurcio Francisco de Assis

Funder

National Counsel of Technological and Scientific Development, CNPq

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40744-016-0036-0.pdf

Reference22 articles.

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379–90.

2. Boonen A, van der Linden SM. The burden of ankylosing spondylitis. J Rheumatol Suppl. 2006;78:4–11.

3. Boonen A, van der Heijde D, Landewé R, Spoorenberg A, Schouten H, Rutten-van Mölken M, Guillemin F, Dougados M, Mielants H, de Vlam K, van der van der Tempel H, Linden S. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis. 2002;61(5):429–37.

4. Azevedo VF, Rossetto CN, Lorencetti PG, Tramontin MY, Fornazari B, Araújo DV. Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system. Rev Bras Reumatol. 2016;56(2):131–7. doi: 10.1016/j.rbr.2015.06.002 .

5. Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896–904.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Adalimumab Therapy for Ankylosing Spondylitis;Current Rheumatology Reviews;2024-12

2. Direct Medical Costs and Healthcare Resource Utilization of Treating Patients With Two Clinical Subtypes of Axial Spondyloarthritis in Colombia;Value in Health Regional Issues;2022-11

3. Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China;Frontiers in Public Health;2020-11-24

4. RUNX3 Polymorphisms Affect the Risk of Ankylosing Spondylitis;Medical Science Monitor;2020-03-05

5. Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study;Current Medical Research and Opinion;2020-02-11